Other OTC Pharmaceuticals - Philippines

  • Philippines
  • In 2024, the revenue in the Other OTC Pharmaceuticals market in the Philippines reached a significant amount of US$181.90m.
  • It is projected that this market will experience an annual growth rate of 2.82% from 2024 to 2029 (CAGR 2024-2029).
  • When comparing the global market, it is noteworthy that the in the United States generated the highest revenue in this market, amounting to US$7,171.00m in 2024.
  • In terms of per capita revenue, in 2024, each person in the Philippines contributed US$1.53 in revenue to the Other OTC Pharmaceuticals market.
  • The demand for Other OTC Pharmaceuticals in the Philippines is driven by the country's strong cultural reliance on self-medication.

Key regions: Europe, Germany, United States, Brazil, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in the Philippines has been experiencing steady growth in recent years. This can be attributed to several factors, including customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Philippines play a significant role in the development of the Other OTC Pharmaceuticals market. Filipino consumers have shown a growing preference for self-medication and a desire for easily accessible healthcare products. This has led to an increased demand for over-the-counter pharmaceuticals, as they provide convenience and affordability. Additionally, the rising awareness of health and wellness among the population has further fueled the demand for OTC pharmaceuticals.Trends in the market also contribute to the growth of the Other OTC Pharmaceuticals market in the Philippines. One major trend is the increasing availability of OTC medications in various retail channels, such as pharmacies, supermarkets, and convenience stores. This allows consumers to easily purchase these products without the need for a prescription. Furthermore, manufacturers are focusing on product innovation and expanding their product portfolios to cater to the specific needs of the Filipino market. This includes the introduction of new formulations, flavors, and packaging options.Local special circumstances in the Philippines also impact the development of the Other OTC Pharmaceuticals market. The country has a large population with limited access to healthcare facilities, especially in rural areas. As a result, many Filipinos rely on OTC medications to address common health issues and minor ailments. Additionally, the prevalence of self-medication practices and the cultural belief in the efficacy of certain traditional remedies contribute to the demand for OTC pharmaceuticals.Underlying macroeconomic factors also play a role in the growth of the Other OTC Pharmaceuticals market in the Philippines. The country has been experiencing steady economic growth, which has led to an increase in disposable income and purchasing power among the population. This has allowed more individuals to afford OTC medications and invest in their health and well-being. Additionally, the government's efforts to improve healthcare infrastructure and promote universal healthcare coverage have also contributed to the growth of the market.In conclusion, the Other OTC Pharmaceuticals market in the Philippines is developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The growing preference for self-medication, increasing availability of OTC medications, and the need for easily accessible healthcare products are driving the growth of the market. Additionally, the cultural beliefs in traditional remedies and the government's focus on improving healthcare infrastructure further contribute to the development of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)